This is a prospective single-center study for the follow-up of SARS-CoV-2 positive patients in the district of Konstanz (LKN). As part of the coronavirus pandemic, patients with SARS-CoV-2 infection are currently being treated in the clinics of the LKN's health network at the Singen (Hegau-Bodensee Clinic) and Konstanz (Konstanz Clinic) locations. So far, there is little data on the long-term effects of SARS-CoV-2 infection. As part of this study, the disease progression of these patients will be monitored. Study objective: Prospective, controlled follow-up observation of SARS-CoV-2 positive patients regarding their secondary diseases and quality of life.
Inclusion Criteria:
A Inclusion Criteria of SARS-CoV-2 positive patients:
Patient must meet all of the following criteria.
1. Positive test for SARS-CoV-2 by PCR
2. Signed informed consent and privacy policy
B Inclusion Criteria of the control Group:
Volunteer must meet all of the following criteria.
1. No contact to SARS-CoV-2 positive patients
2. negative SARS-CoV-2 antibody test
3. Signed informed consent and privacy policy
Exclusion Criteria:
Patient/Volunteer will be excluded if any of the following conditions apply:
1. Patient/Volunteer age < 18 years
2. Patient/Volunteer who are unable to read the information and understand the nature of
the study
3. Patient/Volunteer participate in any other clinical study
Hegau-Bodensee-Klinikum Singen
Singen, Baden-Württemberg, Germany
Marc Kollum, PD Dr. med., Principal Investigator
Hegau-Bodensee-Klinikum Singen